NRIX - Nurix Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$32.20
DETAILS
HIGH:
$36.00
LOW:
$28.00
MEDIAN:
$32.00
CONSENSUS:
$32.20
UPSIDE:
84.00%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 77.5% |
| EBIT Margin | -314.0% |
| EBITDA Margin | -291.5% |
| Operating Margin | -340.2% |
| Pretax Margin | -314.0% |
| Cont. Ops Margin | -314.9% |
| Net Margin | -314.9% |
| Bottom Line Margin | -314.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 7.02 |
| Quick Ratio | 7.02 |
| Solvency Ratio | -1.644 |
| Cash Ratio | 2.86 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-5.54
Peers avg: 18.1
|
| PEG Ratio | -0.94 |
| Forward PEG | -0.94 |
| Price/Book | 2.72 |
| Price/Sales | 17.45 |
| Price/FCF | -5.56 |
| Price/Op Cash Flow | -5.87 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0810 |
| Debt/Equity | 0.1034 |
| Debt/Capital | 0.0937 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.28 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.16 |
| Operating Cash Flow Ratio | -2.885 |
| Operating Cash Flow/Sales | -297.1% |
| Free Cash Flow/Operating Cash Flow | 105.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -4.48 |
| Capital Expenditure Coverage | -17.82 |
| Dividend + Capital Expenditure Coverage | -17.82 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.97 |
| EPS | -3.051 |
| Debt/Share | 0.6430 |
| Cash/Share | 6.84 |
| Book Value/Share | 6.22 |
| Tangible BV/Share | 6.22 |
| Equity/Share | 6.22 |
| Operating Cash Flow/Share | -2.878 |
| Capital Expenditure/Share | 0.162 |
| FCF/Share | -3.040 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.003 |
| Earnings Before Tax/EBIT | 0.923 |
| Price/Fair Value | 2.72 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | -0.3% |
| Enterprise Value Multiple | -5.20 |